This post originally appeared on Svn Space.

Millions of Americans are turning to CBD to combat anxiety and insomnia. According to a August 2019 Gallup poll, 20% of CBD users cite relief from anxiety while 11% cite relief from insomnia as primary reasons for use, trailing only pain relief as the leading driver.

“CBD has a promising role in the management of anxiety and sleep disorders.”

Yet, in spite of widespread usage, there is still a scarcity of clinical data supporting if and how CBD may be beneficial for anxiety or insomnia.   The few small controlled trials and case series around CBD use for anxiety or sleep on PubMed, a biomedical and life science literature database maintained by the US National Library of Medicine, conclude with the same sentiment – that “CBD has a promising role in the management of anxiety and sleep disorders. However, more clinical and longitudinal studies with standardized approaches to dosing and outcome measurements are needed to determine the appropriate dosing strategy for CBD and its place in therapy.”

Given the remarkable lack of formal clinical studies, there is still a lot of confusion about how CBD works, what it exactly does, not to mention the basics, namely when, what and how much to take.  So, what do we already know about these topics based on existing medical research?  And, more importantly, what are we doing to learn more?  Read on to find out.

 “Serotonin, otherwise known as the “hormone of happiness”, plays an important role in emotion, mood, and anxiety. CBD may be directly activating the serotonin receptors.”

The Anxiolytic Effects of CBD

While CBD is believed to have neuroprotective, antidepressive, and anxiolytic benefits, the mechanisms of action by which CBD decreases anxiety are still unclear.  Most evidence points towards a calming effect in the central nervous system, with studies supporting CBD’s ability to interact with serotonin receptors and GABA receptors in the brain.  Serotonin, otherwise known as the “hormone of happiness”, plays an important role in emotion, mood, and anxiety. CBD may be directly activating the serotonin receptors, thereby delivering an anti-anxiety effect, though the scale of this impact is still being explored.  CBD may also increase the serotonin supply in a second way, essentially, by enabling more serotonin to remain in the synapses in the presence of cannabidiol.  GABA, on the other hand, is the main ‘inhibitory’ neurotransmitter, reducing excess activity in the brain and promoting relaxation. There is evidence that CBD may be modifying the way the GABA receptor works, amplifying its natural calming effects.

Current Research

Cannabidiol in Anxiety and Sleep: A Large Case Series is likely the most recent and broadest sample study conducted on humans to this point.  This case series was designed to determine whether CBD helps improve sleep and/or anxiety in a clinical population.  The 2019 study concluded that CBD may hold a benefit for anxiety-related disorders.  With nearly all patients receiving daily doses of CBD 25 mg/day in capsule form, anxiety scores declined in nearly 80% of the study participants within the first month and remained decreased during the study duration. Sleep scores improved within the first month in two-thirds of the patients, but then fluctuated over time.  On another positive note, CBD was well tolerated in almost all patients, in line with other studies that concluded that CBD appears to be better tolerated than routine psychiatric medications.

Other research, focused on the effect of CBD on sleep quality and the sleep-wake cycles in animal models, found an increase in the total percentage of sleep in rats after administration of mid-to-high-dose CBD injections as compared to placebo.   However, there are conflicting findings suggesting that cannabinoid concentration, dose, and route of administration may have varying effects on sleep quality and insomnia symptoms.

“We are truly in the midst of a massive – perhaps the largest – uncontrolled human experiment, with tens of millions of people turning to CBD for relief.”

Looking Forward

Basically, while there is promise, we simply don’t know enough as to why CBD may help these prevalent conditions, nor do we have sufficient data on the most effective modes of administration.  That’s exactly why the Wholistic Research and Education Foundation has decided to partner with University of California, Los Angeles (UCLA) to explore how CBD specifically and cannabis in general may affect insomnia.  We will be kicking off Phase 1 of a multi-phase Therapeutic Impact of Cannabis for Insomnia project with researchers from UCLA.  During this initial phase, adult users will be surveyed to identify the types of cannabis products they are currently taking for insomnia, as well details on dose, frequency, timing of use, and delivery methods most associated with therapeutic benefit.   Leveraging the learnings from the survey, we plan to proceed with additional research, including a randomized, placebo-controlled clinical trial to evaluate CBD and THC for sleep disorders.

We are truly in the midst of a massive – perhaps the largest – uncontrolled human experiment, with tens of millions of people turning to CBD for relief.  In the absence of evidence-based guidance from their healthcare professions, many literally seek counsel from natural food or vitamin shop clerks.  To make matters worse, there is a large and growing black market, as well as conflicting regulatory guidelines for CBD supplements which vary from state to state.  Given the urgency of the current state of affairs, I see it as our ethical responsibility to act to support research for the safety, tolerability, and efficacy of CBD, and do so expediently.  The opportunity to benefit millions as well as prevent potential harm is up to all of us.  To join Wholistic Research & Education on their mission, please visit here.

Written By:  Pelin Thorogood is a tech executive turned social entrepreneur/venture philanthropist and is the currently President and Co-Founder of the Wholistic Research and Education Foundation, a public non-profit (501c3) dedicated to cannabis research, education, and advocacy. Pelin also serves as Chief Health and Research Contributor for Svn Space, contributing monthly articles and content around research and education for the Cannabis industry.

Support Wholistic Research and Education Foundation in their efforts to assess the potential health benefits and risks for Cannabis and CBD by making a donation. 100% of your donation will fund  Wholistic Research and Education Foundation’s efforts to help answer just HOW and WHY CBD works (not if). If CBD has helped you or a loved one, please visit this link and click “Donate Today”. Be the change you want to see in the world, and join this modern Hemp revolution. Thank you.

*The contents of this website are not intended to substitute for professional medical advice, diagnosis or treatment. Although we take efforts to keep the information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Always consult your physician for personalized medical advice. Always seek the advice of a physician or other qualified healthcare provider with any questions regarding a medical condition. Never disregard or delay seeking professional medical advice or treatment because of something you have read on the Svn Space website.